NAZEM FARZAD has filed 3 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 45000 shares of Nautilus Biotechnology, Inc. ($NAUT) on June 23, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 23, 2025 | Nautilus Biotechnology, Inc. | $NAUT | NAZEM FARZAD | Director | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 126,148,469 | 9999.99% | 0.04% |
| June 14, 2024 | Nautilus Biotechnology, Inc. | $NAUT | NAZEM FARZAD | Director | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2023 | Nautilus Biotechnology, Inc. | $NAUT | NAZEM FARZAD | Director | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |